TEVA-PREDNISOLONE 1 %
PREDNISOLONE ACETATE : 1 % · DIN 00700401 · TEVA CANADA LIMITED
Health Canada status: MARKETED
What is TEVA-PREDNISOLONE?
TEVA-PREDNISOLONE 1 % contains PREDNISOLONE ACETATE : 1 %. It is listed in the Health Canada Drug Product Database under DIN 00700401, held by TEVA CANADA LIMITED, supplied as SUSPENSION for OPHTHALMIC administration. Health Canada currently lists it as marketed, status dated 20-Apr-2018. Nexara Health is a licensed Canadian wholesale distributor (DEL 3-002896-A) and can source this product for hospitals, pharmacies and clinics. Availability and lead time are confirmed per order.
Product details and regulatory record
| DIN | 00700401 |
|---|---|
| Brand name | TEVA-PREDNISOLONE |
| Generic / active ingredient | PREDNISOLONE ACETATE : 1 % |
| Manufacturer | TEVA CANADA LIMITED |
| Strength | 1 % |
| Dosage form | SUSPENSION |
| Route of administration | OPHTHALMIC |
| Schedule | Prescription |
| ATC code | S01BA04 PREDNISOLONE |
| AHFS class | 52:08.08 |
| Biosimilar | No |
| Health Canada status | MARKETED |
| Status date | 20-Apr-2018 |
| Original market date | 1986-12-31 00:00:00 |
What can be used instead?
Other Canadian products sharing ATC code S01BA04 PREDNISOLONE. 4 of 17 DINs in this group are currently marketed — marketed products are listed first, because that is what can actually be bought. These tables describe supply, not clinical equivalence: substitution rests with the prescriber or pharmacist, and interchangeability is determined provincially.
| Product | Strength | Form | Manufacturer | Health Canada status | DIN |
|---|---|---|---|---|---|
| MINIMS PREDNISOLONE SODIUM PHOSPHATE | 0.5 % | DROPS | BAUSCH & LOMB INC | MARKETED | DIN 02148498 |
| PRED FORTE | 1 % | SUSPENSION | ABBVIE CORPORATION | MARKETED | DIN 00301175 |
| SANDOZ PREDNISOLONE | 1 % | SUSPENSION | SANDOZ CANADA INCORPORATED | MARKETED | DIN 01916203 |
| AK TATE OPH SUS 1% | 1 % | SUSPENSION | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 00622931 |
| DIOPRED SUSPENSION 1% | 1 % | SUSPENSION | SANDOZ CANADA INCORPORATED | CANCELLED POST MARKET | DIN 02023768 |
| INFLAMASE FORTE OPH SOLN 1% | 10 MG | LIQUID | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00756164 |
| INFLAMASE FORTE OPHTHALMIC SOLUTION 1% | 1 % | SOLUTION | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | CANCELLED POST MARKET | DIN 02133318 |
| INFLAMASE MILD | .125 % | LIQUID | NOVARTIS OPHTHALMICS NOVARTIS PHARMACEUTICALS (CANADA) INC | CANCELLED POST MARKET | DIN 02133296 |
| INFLAMASE OPH SOLN 0.125% | 1.25 MG | LIQUID | IOLAB PHARMACEUTICALS | CANCELLED POST MARKET | DIN 00756172 |
| PMS-PREDNISOLONE SODIUM PHOSPHATE OPHTHALMIC SOLUTION FORTE | 1 % | SOLUTION | PHARMASCIENCE INC | DORMANT | DIN 01954237 |
Who else supplies PREDNISOLONE worldwide?
Nexara tracks national medicine registries and published price lists across multiple markets. PREDNISOLONE appears in 190 registered pack listings across 10 markets, published on 9 different national price bases. Where a Canadian route is closed, that is where an alternative route of supply starts — subject to the import rules in both countries.
Registered listings are not stock. Ask us to confirm what can actually be sourced for your order.
How can I get it?
Nexara Health supplies this product to licensed Canadian buyers — pharmacies, hospitals, clinics, licensed distributors, and clinical trial sponsors or their CROs. We confirm stock, pack size, expiry and pricing at the time of quotation. If the product is on backorder or in shortage, we identify equivalent alternatives and import options where permitted.
Ordering questions
Who can buy this from Nexara?
Licensed entities only. Nexara holds Health Canada establishment licence DEL 3-002896-A and ships only to a licensed address.
Is there a minimum order?
Yes, set per product line and per pack multiple rather than on the order total, so you are never asked to buy a part-pack. The minimum for this line is confirmed with your quote.
What is the lead time?
Confirmed per order at quotation, and it depends on current stock position and whether the product is in shortage.
Can Nexara supply this for a clinical trial?
Yes — comparator and background-therapy supply, including sourcing from other markets where a Canadian pack will not satisfy the protocol. Clinical trial supply.